Genetic or pharmacological inactivation of CREBBP sensitizes B-cell Acute Lymphoblastic Leukemia to Ferroptotic Cell Death upon BCL2 Inhibition
RNA-seq (gene expression) · human · 24 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Acute lymphoblastic leukemiaThis series is part of our curated briefing on it.
- Samples
- 24 samples: 24 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- CREBBP inactivation sensitizes B cell acute lymphoblastic leukemia to ferroptotic cell death upon BCL2 inhibitionNature communications · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE248265_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1043135 and SRA study SRP473054. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 24 sample titles: 24 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7910445 SLX-22618.B5_DMSO_1_hs
- GSM7910446 SLX-22618.4B7_DMSO_1_hs
- GSM7910447 SLX-22618.B5_DMSO_2_hs
- GSM7910448 SLX-22618.4B7_DMSO_2_hs
- GSM7910449 SLX-22618.B5_DMSO_3_hs
- GSM7910450 SLX-22618.4B7_DMSO_3_hs
- GSM7910451 SLX-22618.B5_Ven_20nm_1_hs
- GSM7910452 SLX-22618.4B7_Ven_20nm_1_hs
- GSM7910453 SLX-22618.B5_Ven_20nm_2_hs
- GSM7910454 SLX-22618.4B7_Ven_20nm_2_hs
- GSM7910455 SLX-22618.B5_Ven_20nm_3_hs
- GSM7910456 SLX-22618.4B7_Ven_20nm_3_hs
- GSM7910457 SLX-22619.B5_DMSO_1_hs
- GSM7910458 SLX-22619.4B7_DMSO_1_hs
- GSM7910459 SLX-22619.B5_DMSO_2_hs
- GSM7910460 SLX-22619.4B7_DMSO_2_hs
- GSM7910461 SLX-22619.B5_DMSO_3_hs
- GSM7910462 SLX-22619.4B7_DMSO_3_hs
- GSM7910463 SLX-22619.B5_Ven_res_1_hs
- GSM7910464 SLX-22619.4B7_Ven_res_1_hs
- GSM7910465 SLX-22619.B5_Ven_res_2_hs
- GSM7910466 SLX-22619.4B7_Ven_res_2_hs
- GSM7910467 SLX-22619.B5_Ven_res_3_hs
- GSM7910468 SLX-22619.4B7_Ven_res_3_hs
- GSE115656 Alternative splicing analysis of pediatric B-cell acute lymphoblastic leukemia compared to normal bone marrow derived pro-B cells 38 samples same disease briefing · shares lymphoblastic
- GSE12995 Expression data for diagnosis acute lymphoblastic leukemia samples 175 samples same disease briefing · shares lymphoblastic
- GSE160298 The chromatin accessibility landscape of T-Cell Acute Lymphoblastic Leukemia 80 samples same disease briefing · shares lymphoblastic
- GSE13425 Expression data from ALL patients included in the set used to construct a classification signature (COALL cohort) 190 samples same disease briefing
- GSE154675 PHF6 Interacts with LMO2 During Normal Haematopoiesis and in Leukaemia and Regulates the Level of Gene Expression and Genome Integrity 41 samples same disease briefing
- GSE193713 Genome-wide maps of chromatin state for histone modifications and chromatin remodeling factors in WT and PHF6-KO conditions in Jurkat T-ALL cells. 20 samples same disease briefing
- GSE18198 Expression profile of human T-ALL cell lines treated with DMSO or SAHM1 12 samples same disease briefing
- GSE316603 HDAC3 inhibition as a therapeutic strategy in T-cell acute lymphoblastic leukemia via the TYK2-STAT1-BCL2 signaling pathway 12 samples shares bcl2, lymphoblastic, inhibition
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.